We are live on ! Find out more
AVXL icon

Anavex Life Sciences

62 hedge funds and large institutions have $41.5M invested in Anavex Life Sciences in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 13

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

2% more funds holding

Funds holding: 6162 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

1.08% less ownership

Funds ownership: 24.88%23.8% (-1.1%)

24% less capital invested

Capital invested by funds: $54.7M → $41.5M (-$13.2M)

87% less call options, than puts

Call options by funds: $593K | Put options by funds: $4.65M

Holders
62
Holders Change
+1
Holders Change %
+1.64%
% of All Funds
1.55%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
22
Reduced
13
Closed
5
Calls
$593K
Puts
$4.65M
Net Calls
-$4.05M
Net Calls Change
+$1.46M
Name Holding Trade Value Shares
Change
Change in
Stake
PWAM
1
Park West Asset Management
California
$11.9M -$1.91M -429,267 -13%
BlackRock
2
BlackRock
New York
$7.42M +$404K +90,812 +5%
Vanguard Group
3
Vanguard Group
Pennsylvania
$6.86M +$172K +38,758 +2%
KCM
4
Knoll Capital Management
Florida
$3M
State Street
5
State Street
Massachusetts
$2.52M +$17.1K +3,854 +0.6%
Northern Trust
6
Northern Trust
Illinois
$1.77M -$7.68K -1,727 -0.4%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$1.29M +$50.2K +11,297 +4%
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$979K -$127K -28,536 -11%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$459K -$1.08K -242 -0.2%
TCIM
10
TIAA CREF Investment Management
New York
$401K
Group One Trading
11
Group One Trading
Illinois
$317K +$266K +59,828 +356%
SFG
12
SNS Financial Group
Minnesota
$290K +$311K +70,000 New
TA
13
Teachers Advisors
New York
$280K
CS
14
Credit Suisse
Switzerland
$257K +$82.2K +18,502 +43%
California State Teachers Retirement System (CalSTRS)
15
California State Teachers Retirement System (CalSTRS)
California
$247K -$23.5K -5,283 -8%
Morgan Stanley
16
Morgan Stanley
New York
$247K +$20.6K +4,640 +8%
Wells Fargo
17
Wells Fargo
California
$236K +$73.3K +16,488 +41%
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
$224K +$2.78K +626 +1%
Charles Schwab
19
Charles Schwab
California
$212K
EWM
20
Edge Wealth Management
New York
$209K -$44.4K -10,000 -17%
RhumbLine Advisers
21
RhumbLine Advisers
Massachusetts
$169K +$2.65K +595 +1%
New York State Common Retirement Fund
22
New York State Common Retirement Fund
New York
$139K
Bank of America
23
Bank of America
North Carolina
$138K +$6.52K +1,467 +5%
Deutsche Bank
24
Deutsche Bank
Germany
$135K -$262K -58,856 -64%
AllianceBernstein
25
AllianceBernstein
Tennessee
$123K

AVXL Hedge Fund Activity: Q3 2017 in Review

62 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q3 2017, worth a combined $41.5M — down 24% from $54.7M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new AVXL positions and 5 closed out — a net gain of 2 holders — while 22 added to existing stakes and 13 trimmed.

The largest buyer was BlackRock, adding an estimated $404K. The largest seller was Park West Asset Management, cutting an estimated $1.91M.

  • 62 institutional investors held Anavex Life Sciences (AVXL) as of Q3 2017, up from 61 in Q2 2017.
  • Funds reported $41.5M of Anavex Life Sciences stock for Q3 2017, down 24% quarter-over-quarter.
  • 7 funds opened new Anavex Life Sciences positions in Q3 2017 and 5 closed out, a net change of +2 holders.
  • The largest Anavex Life Sciences buyer in Q3 2017 was BlackRock, an estimated $404K added.
  • The largest Anavex Life Sciences seller in Q3 2017 was Park West Asset Management, an estimated $1.91M sold.

Based on aggregated 13F filings for Q3 2017.